FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014129856> ?p ?o ?g. }

• W3014129856 endingPage "402" @default.
• W3014129856 startingPage "396" @default.
• W3014129856 abstract "Childhood adversity is reliably associated with immune alterations in adulthood, including increases in inflammatory processes. However, relatively few studies have investigated these associations in clinical populations such as cancer patients who are at risk for negative immune-related health outcomes. The current study tested the hypothesis that childhood maltreatment would be associated with alterations in immune-related gene expression in monocytes from women with breast cancer.Women (n = 86) were recruited after diagnosis with early-stage breast cancer but before onset of adjuvant therapy with radiation, chemotherapy, and/or endocrine therapy. Participants completed questionnaires to assess childhood maltreatment (Childhood Trauma Questionnaire; CTQ) and depressive symptoms (Center for Epidemiologic Studies Depression Scale; CES-D) and provided blood samples for immune assessment. CD14+ monocytes were isolated for RNA extraction and gene expression analyses.Based on responses to the CTQ, 28% of participants were classified as experiencing physical and/or emotional abuse or neglect and 7% as experiencing sexual abuse. Genome-wide transcriptional profiling of isolated monocytes identified 202 gene transcripts that differed in average expression level by > 25% over the range of maltreatment exposure. Bioinformatics analyses of those gene transcripts identified a significantly greater prevalence of NF-κB-binding motifs within the promoters of up-regulated vs. down-regulated genes (p = .028) in women exposed to childhood maltreatment, indicating greater inflammatory signaling. Parallel analyses of Type I interferon signaling also indicated greater prevalence of Interferon Response Factor (IRF)-related binding sites in women with a childhood maltreatment history (p = .020). Results remained significant in analyses controlling for current depression; however, NF-κB and IRF-related gene expression was higher in women with both maltreatment exposure and current depression.In women recently diagnosed with early-stage breast cancer, childhood maltreatment was associated with increases in the classical NF-kB-related pro-inflammatory signaling pathway and with increases in the Type I interferon system. These results suggest a broad pattern of chronic immunologic activation in breast cancer patients with a history of childhood maltreatment, particularly those who are currently experiencing clinically significant depressive symptoms. These findings have implications for the long-term health and well-being of maltreatment exposed breast cancer patients." @default.
• W3014129856 created "2020-04-10" @default.
• W3014129856 creator A5005936736 @default.
• W3014129856 creator A5011136538 @default.
• W3014129856 creator A5032010068 @default.
• W3014129856 creator A5036933917 @default.
• W3014129856 creator A5077706003 @default.
• W3014129856 creator A5089586569 @default.
• W3014129856 date "2020-08-01" @default.
• W3014129856 modified "2023-09-30" @default.
• W3014129856 title "Childhood maltreatment and monocyte gene expression among women with breast cancer" @default.
• W3014129856 cites W1584609572 @default.
• W3014129856 cites W1804627766 @default.
• W3014129856 cites W1870147430 @default.
• W3014129856 cites W1964368905 @default.
• W3014129856 cites W2000873474 @default.
• W3014129856 cites W2002736415 @default.
• W3014129856 cites W2003338662 @default.
• W3014129856 cites W2004931363 @default.
• W3014129856 cites W2013990847 @default.
• W3014129856 cites W2051369986 @default.
• W3014129856 cites W2058648826 @default.
• W3014129856 cites W2074821083 @default.
• W3014129856 cites W2078505577 @default.
• W3014129856 cites W2078619626 @default.
• W3014129856 cites W2084231086 @default.
• W3014129856 cites W2095838749 @default.
• W3014129856 cites W2103018275 @default.
• W3014129856 cites W2107567947 @default.
• W3014129856 cites W2109203270 @default.
• W3014129856 cites W2112778345 @default.
• W3014129856 cites W2115394480 @default.
• W3014129856 cites W2116839388 @default.
• W3014129856 cites W2117692326 @default.
• W3014129856 cites W2130675837 @default.
• W3014129856 cites W2137989607 @default.
• W3014129856 cites W2138970660 @default.
• W3014129856 cites W2139463883 @default.
• W3014129856 cites W2140711005 @default.
• W3014129856 cites W2152934881 @default.
• W3014129856 cites W2155444336 @default.
• W3014129856 cites W2156303855 @default.
• W3014129856 cites W2167409896 @default.
• W3014129856 cites W2169510064 @default.
• W3014129856 cites W2169690159 @default.
• W3014129856 cites W2309280425 @default.
• W3014129856 cites W2505201035 @default.
• W3014129856 cites W2599257356 @default.
• W3014129856 cites W2614257047 @default.
• W3014129856 cites W2620868499 @default.
• W3014129856 cites W2753476712 @default.
• W3014129856 cites W2902125411 @default.
• W3014129856 cites W2904576258 @default.
• W3014129856 cites W2915157760 @default.
• W3014129856 cites W2946048312 @default.
• W3014129856 cites W2967035454 @default.
• W3014129856 doi "https://doi.org/10.1016/j.bbi.2020.04.001" @default.
• W3014129856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32247915" @default.
• W3014129856 hasPublicationYear "2020" @default.
• W3014129856 type Work @default.
• W3014129856 sameAs 3014129856 @default.
• W3014129856 citedByCount "21" @default.
• W3014129856 countsByYear W30141298562020 @default.
• W3014129856 countsByYear W30141298562021 @default.
• W3014129856 countsByYear W30141298562022 @default.
• W3014129856 countsByYear W30141298562023 @default.
• W3014129856 crossrefType "journal-article" @default.
• W3014129856 hasAuthorship W3014129856A5005936736 @default.
• W3014129856 hasAuthorship W3014129856A5011136538 @default.
• W3014129856 hasAuthorship W3014129856A5032010068 @default.
• W3014129856 hasAuthorship W3014129856A5036933917 @default.
• W3014129856 hasAuthorship W3014129856A5077706003 @default.
• W3014129856 hasAuthorship W3014129856A5089586569 @default.
• W3014129856 hasBestOaLocation W30141298562 @default.
• W3014129856 hasConcept C104317684 @default.
• W3014129856 hasConcept C121608353 @default.
• W3014129856 hasConcept C126322002 @default.
• W3014129856 hasConcept C143998085 @default.
• W3014129856 hasConcept C190385971 @default.
• W3014129856 hasConcept C203014093 @default.
• W3014129856 hasConcept C2780416715 @default.
• W3014129856 hasConcept C2993946119 @default.
• W3014129856 hasConcept C3017944768 @default.
• W3014129856 hasConcept C41091548 @default.
• W3014129856 hasConcept C519513126 @default.
• W3014129856 hasConcept C530470458 @default.
• W3014129856 hasConcept C54355233 @default.
• W3014129856 hasConcept C70410870 @default.
• W3014129856 hasConcept C71924100 @default.
• W3014129856 hasConcept C86803240 @default.
• W3014129856 hasConcept C8891405 @default.
• W3014129856 hasConcept C99454951 @default.
• W3014129856 hasConceptScore W3014129856C104317684 @default.
• W3014129856 hasConceptScore W3014129856C121608353 @default.
• W3014129856 hasConceptScore W3014129856C126322002 @default.
• W3014129856 hasConceptScore W3014129856C143998085 @default.
• W3014129856 hasConceptScore W3014129856C190385971 @default.
• W3014129856 hasConceptScore W3014129856C203014093 @default.

• next